Federal Register #2026-14838

DEA Requests Comments on Recordkeeping for Partial Fills of Schedule II Prescriptions

This notice from the Drug Enforcement Administration (DEA), part of the Department of Justice (DOJ), seeks public input on proposed changes to recordkeeping requirements for partial fills of Schedule II controlled substance prescriptions. - Government Buyer: - Department of Justice (DOJ) - Drug Enforcement Administration (DEA) - Purpose: - Soliciting public comments on revised information collection requirements - Focused on recordkeeping for partial fills of Schedule II controlled substances - Requirements: - DEA registrants (e.g., pharmacies, pharmacists) must maintain detailed records for each controlled substance dispensed - Records must include date, quantity, and dispenser information - Feedback is requested on the necessity, accuracy, and burden of these requirements - No procurement of products or services is involved - No OEMs or vendors are mentioned - This is not a solicitation for goods or services, but a regulatory compliance notice

Description

The Drug Enforcement Administration (DEA), Department of Justice (DOJ), is submitting an information collection request to the Office of Management and Budget (OMB) for review and approval. This collection pertains to recordkeeping requirements for partial fills of prescriptions for Schedule II controlled substances. The collection is a revision of a previously approved collection and involves DEA registrants maintaining accurate records of controlled substances dispensed. Comments on this collection are accepted until September 21, 2026.

View original listing